ASX - By Stock
|
VLA |
Re:
These results relate to poster ONLY
|
|
mitchlol
|
27 |
7.1K |
1 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
27
|
7.1K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
These results relate to poster ONLY
|
|
mitchlol
|
27 |
7.1K |
2 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
27
|
7.1K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
These results relate to poster ONLY
|
|
mitchlol
|
27 |
7.1K |
0 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
27
|
7.1K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
These results relate to poster ONLY
|
|
mitchlol
|
27 |
7.1K |
0 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
27
|
7.1K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Promising Results CAPRA Melanoma Trial expand to 50 patients
|
|
mitchlol
|
38 |
10K |
2 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
38
|
10K
|
2
|
|
ASX - By Stock
|
ZMM |
Re:
Ann: Quantify Technology to Target China Smart Cities
|
|
mitchlol
|
38 |
17K |
1 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
38
|
17K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
Abstract CT114 withheld due to inclusion in official press program
|
|
mitchlol
|
42 |
17K |
4 |
03/04/17 |
03/04/17 |
ASX - By Stock
|
42
|
17K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Abstract CT114 withheld due to inclusion in official press program
|
|
mitchlol
|
42 |
17K |
9 |
03/04/17 |
03/04/17 |
ASX - By Stock
|
42
|
17K
|
9
|
|
ASX - By Stock
|
LRS |
Re:
Ann: Annual Report to shareholders
|
|
mitchlol
|
5 |
3.0K |
0 |
31/03/17 |
31/03/17 |
ASX - By Stock
|
5
|
3.0K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Bioshares Report and Recommendation
|
|
mitchlol
|
35 |
12K |
0 |
30/03/17 |
30/03/17 |
ASX - By Stock
|
35
|
12K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Viralytics to Present New CAVATAK Clinical Data at AACR
|
|
mitchlol
|
65 |
29K |
0 |
26/03/17 |
26/03/17 |
ASX - By Stock
|
65
|
29K
|
0
|
|
ASX - By Stock
|
LRS |
Re:
Ann: Positive Assays Received for Lithium Project - Catamarca
|
|
mitchlol
|
156 |
63K |
3 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
156
|
63K
|
3
|
|